CA1295947C - Medicaments destines au traitement et a la prevention des maladies renales ethepatiques - Google Patents

Medicaments destines au traitement et a la prevention des maladies renales ethepatiques

Info

Publication number
CA1295947C
CA1295947C CA 553884 CA553884A CA1295947C CA 1295947 C CA1295947 C CA 1295947C CA 553884 CA553884 CA 553884 CA 553884 A CA553884 A CA 553884A CA 1295947 C CA1295947 C CA 1295947C
Authority
CA
Canada
Prior art keywords
therapy
prevention
medicine
kidney
isoliquiritigenin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA 553884
Other languages
English (en)
Inventor
Hisao Kakegawa
Hitoshi Matsumoto
Toshio Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIC Corp
Nippon Hypox Laboratories Inc
Original Assignee
Nippon Hypox Laboratories Inc
Dainippon Ink and Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Hypox Laboratories Inc, Dainippon Ink and Chemicals Co Ltd filed Critical Nippon Hypox Laboratories Inc
Priority to CA 553884 priority Critical patent/CA1295947C/fr
Application granted granted Critical
Publication of CA1295947C publication Critical patent/CA1295947C/fr
Expired legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
CA 553884 1987-12-09 1987-12-09 Medicaments destines au traitement et a la prevention des maladies renales ethepatiques Expired CA1295947C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 553884 CA1295947C (fr) 1987-12-09 1987-12-09 Medicaments destines au traitement et a la prevention des maladies renales ethepatiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 553884 CA1295947C (fr) 1987-12-09 1987-12-09 Medicaments destines au traitement et a la prevention des maladies renales ethepatiques

Publications (1)

Publication Number Publication Date
CA1295947C true CA1295947C (fr) 1992-02-18

Family

ID=4137034

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 553884 Expired CA1295947C (fr) 1987-12-09 1987-12-09 Medicaments destines au traitement et a la prevention des maladies renales ethepatiques

Country Status (1)

Country Link
CA (1) CA1295947C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115414341A (zh) * 2022-09-14 2022-12-02 中国农业大学 一种包含α-紫罗兰酮用于抗紫外线暴露引起肾脏损伤的组合物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115414341A (zh) * 2022-09-14 2022-12-02 中国农业大学 一种包含α-紫罗兰酮用于抗紫外线暴露引起肾脏损伤的组合物

Similar Documents

Publication Publication Date Title
US4898890A (en) Medicines for use in the therapy and prevention of kidney and liver diseases
GUERRA et al. Long-term antibiotic therapy in tropical sprue
US9233116B2 (en) Composition containing iridoids and uses thereof
FI84065C (fi) Foerfarande foer framstaellning av isosilybinfri silibinin.
EP0495116B1 (fr) Agent anti-vih
EP0313654B1 (fr) Medicament pour la prophylaxie et le traitement de l'hepatopathie
CA1295947C (fr) Medicaments destines au traitement et a la prevention des maladies renales ethepatiques
JPH0832632B2 (ja) 尿素窒素代謝改善剤
EP0290817B1 (fr) Utilisation d'oxétanocine pour inhiber HIV
EP0014471B1 (fr) Dérivés acylés d'un extrait aqueux d'"Anemarrhénae rhizoma" et agents hypoglycémiques les contenant
JPH09241157A (ja) リソスペルメートｂ含有肝臓保護作用医薬組成物
JPH0662403B2 (ja) 腎臓疾患の治療または予防用薬剤
EP0476391B1 (fr) Composition anti-SIDA contenant cépharanthine comme agent thérapeutique
NL8200509A (nl) Geneesmiddel voor allergiekwalen, immuuncomplexziekten en tumoren; werkwijze voor het behandelen van patienten die hieraan lijden.
WO2007042902A2 (fr) Composition pharmaceutique utilisee comme agent leishmanicide
JP3879938B2 (ja) 抗炎症剤
JPH0119A (ja) 腎機能改善剤
KR930004594B1 (ko) 신장 및 간장 질환의 치료 및 예방용 약제
EP0606497A1 (fr) Remede contre des maladies intestinales infectieuses bacteriennes dues a des biotoxines
JPH08769B2 (ja) 肝臓疾患の治療または予防用薬剤
JPH0426624A (ja) 慢性腎不全改善剤
JPH05504130A (ja) 腫瘍壊死因子拮抗剤
KR100734898B1 (ko) 베타-글루칸을 유효성분으로 포함하는 신장질환 치료용 약학적 조성물
JPH04295480A (ja) 糖尿病治療薬
JPH0717507B2 (ja) 抗血栓剤

Legal Events

Date Code Title Description
MKLA Lapsed